Cargando…

Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer

INTRODUCTION: The transcription factor MYC is overexpressed in 30% of small cell lung cancer (SCLC) tumors and is known to modulate the balance between two major pathways of metabolism: glycolysis and mitochondrial respiration. This duality of MYC underscores the importance of further investigation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cargill, Kasey R., Stewart, C. Allison, Park, Elizabeth M., Ramkumar, Kavya, Gay, Carl M., Cardnell, Robert J., Wang, Qi, Diao, Lixia, Shen, Li, Fan, You-Hong, Chan, Wai Kin, Lorenzi, Philip L., Oliver, Trudy G., Wang, Jing, Byers, Lauren A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461854/ https://www.ncbi.nlm.nih.gov/pubmed/34556188 http://dx.doi.org/10.1186/s40170-021-00270-9

Ejemplares similares

SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer
por: Kundu, Kiran, et al.
Publicado: (2021)

Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung Cancers
por: Cargill, Kasey R., et al.
Publicado: (2021)

Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology
por: Stewart, C. Allison, et al.
Publicado: (2021)

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology
por: Stewart, C. Allison, et al.
Publicado: (2021)

1745P SARS-CoV-2 infects metabolically-primed epithelial cells in lung cancer models
por: Cargill, K.R., et al.
Publicado: (2020)

Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial
por: Della Corte, Carminia Maria, et al.
Publicado: (2022)

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
por: Cardnell, Robert J., et al.
Publicado: (2016)

1735P SARS-CoV-2 infection induces EMT-like molecular changes, including ZEB1-mediated repression of the viral receptor ACE2, in lung cancer models
por: Stewart, C.A., et al.
Publicado: (2020)

1736P Elevated AXL expression following SARS-CoV-2 infection in non-small cell lung cancer
por: Ramkumar, K., et al.
Publicado: (2020)

Integrated Approaches for the Use of Large Datasets to Identify Rational Therapies for the Treatment of Lung Cancers
por: Cardnell, Robert J., et al.
Publicado: (2019)

Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies
por: Cardnell, Robert J., et al.
Publicado: (2017)

A positive feedback loop between Myc and aerobic glycolysis sustains tumor growth in a Drosophila tumor model
por: Wong, Kenneth Kin Lam, et al.
Publicado: (2019)

Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4(+) T Cells in Type 1 Diabetes
por: Martins, Christina P., et al.
Publicado: (2021)

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC
por: Della Corte, Carminia Maria, et al.
Publicado: (2022)

LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1‐p53/c‐Myc axis
por: Oyang, Linda, et al.
Publicado: (2022)

c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses
por: Wang, Xu-Yan, et al.
Publicado: (2022)

Myc/Mycn-mediated glycolysis enhances mouse spermatogonial stem cell self-renewal
por: Kanatsu-Shinohara, Mito, et al.
Publicado: (2016)

CLDN6 Suppresses c–MYC–Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer
por: Qu, Huinan, et al.
Publicado: (2021)

Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017)

MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
por: Wang, Xiaofei, et al.
Publicado: (2022)

Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancer
por: Wu, Yong, et al.
Publicado: (2018)

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer
por: Stewart, C. Allison, et al.
Publicado: (2017)

A murine preclinical syngeneic transplantation model for breast cancer precision medicine
por: Federico, Lorenzo, et al.
Publicado: (2017)

The c-Myc–LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer
por: He, Tian-Lin, et al.
Publicado: (2015)

The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues
por: Goetzman, Eric S., et al.
Publicado: (2018)

PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis
por: Qin, Yi, et al.
Publicado: (2019)

Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells
por: Thorén, Matilda Munksgaard, et al.
Publicado: (2017)

Trametinib Inhibits the Growth and Aerobic Glycolysis of Glioma Cells by Targeting the PKM2/c-Myc Axis
por: Gao, Mingjun, et al.
Publicado: (2021)

MYC-mediated early glycolysis negatively regulates proinflammatory responses by controlling IRF4 in inflammatory macrophages
por: Bae, Seyeon, et al.
Publicado: (2021)

Ginsenoside Rh2 Inhibits Glycolysis through the STAT3/c-MYC Axis in Non-Small-Cell Lung Cancer
por: Sun, Xiaodan, et al.
Publicado: (2021)

Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression
por: Xu, Xinyuan, et al.
Publicado: (2015)

FAM46B Promotes Apoptosis and Inhibits Glycolysis of Prostate Cancer Through Inhibition of the MYC-LDHA Axis
por: Liang, Tao, et al.
Publicado: (2020)

Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c‐myc/hexokinase 2 pathway
por: Yu, Qiang, et al.
Publicado: (2022)

Dioscin Inhibited Glycolysis and Induced Cell Apoptosis in Colorectal Cancer via Promoting c-myc Ubiquitination and Subsequent Hexokinase-2 Suppression
por: Wu, Zhenqian, et al.
Publicado: (2020)

Exosomes Derived From Macrophages Enhance Aerobic Glycolysis and Chemoresistance in Lung Cancer by Stabilizing c-Myc via the Inhibition of NEDD4L
por: Wang, Huan, et al.
Publicado: (2021)

Long Noncoding RNA LINC00551 Suppresses Glycolysis and Tumor Progression by Regulating c-Myc-Mediated PKM2 Expression in Lung Adenocarcinoma
por: Wang, Li, et al.
Publicado: (2020)

S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma
por: Shen, Yifei, et al.
Publicado: (2018)

Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc
por: Wang, Shanwei, et al.
Publicado: (2022)

T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62
por: Daniel, Colin J., et al.
Publicado: (2022)

Long Non-coding RNA MEG3 Activated by Vitamin D Suppresses Glycolysis in Colorectal Cancer via Promoting c-Myc Degradation
por: Zuo, Siyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_90kvmnbir26u105k45ttqu3gbd